Long-term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control

Diabetic Medicine

Volumn 33, Issue 10, 2016, Pages 1422-1426

  Quiros C ^a   Gimenez M ^a   Rios P ^a   Careaga, M ^a   Roca, D ^a   Vidal, M ^a   Conget, I ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CONTINUOUS INFUSION; CONTINUOUS SUBCUTANEOUS INSULIN INFUSION; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT; RETROSPECTIVE STUDY; TREATMENT INDICATION;

EID: 84987810733     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13094     Document Type: Article

References (16)

1. Pickup JC, Sutton AJ. Severe hypoglycemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008; 25: 765–774.
2. Bruttomesso D, Costa S, Baritutussio A. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin theraphy. Diabet Metab Res Rev 2009; 25: 99–111.
3. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for Type 1 diabetes mellitus. Cochrane Database Syst Rev 2010; 1: CD005103.
4. American Diabetes Association. Standards of medical care in diabetes 2015. Diabetes Care 2015; 38: S1.
5. Pickup JC, Hammond P. NICE guidance on continuous subcutaneous insulin infusion 2008: review of the technology appraisal guidance. Diabet Med 2009; 26: 1–4.
6. Giménez M, Conget I, Jansà M, Vidal M, Chiganer G, Levy I. Efficacy of continuous subcutaneous insulin infusion in Type 1 diabetes: a 2-year perspective using the established criteria for funding from a National Health Service. Diabet Med 2007; 24: 1419–1423.
7. American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association workgroup on hypoglycemia. Diabetes Care 2005; 28: 1245–1249.
8. Carlsson BM, Attvall S, Clements M, Gumpeny SR, Pivodic A, Sternemalm L et al. Insulin pump – long-term effects on glycemic control: an observational study at 10 diabetes clinics in Sweeden. Diabetes Technol Ther 2013; 15: 302–307.
9. Orr CJ, Hopman W, Yen JL, Houlden RL. Long-term efficacy of insulin pump therapy on glycemic control in adults with Type 1 diabetes mellitus. Diabetes Technol Ther 2015; 17: 49–54.
10. Dovc K, Starc ST, Lusa L, Bratanic N, Zerjav-Tansek M, Kotnic P et al. Improved metabolic control in pediatric patients with Type 1 diabetes: a nationwide prospective 12-year time trends analysis. Diabetes Technol Ther 2014; 16: 33–40.
11. Danne T, Battelino T, Jarosz-Chobot P, Kordonouri O, Pánkowska E, Ludvigsson J et al. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with Type 1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia 2008; 51: 1594–1601.
12. Nixon R, Folwell R, Pickup JC. Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion. Diabet Med 2014; 31: 1174–1177.
13. 1c measurement and gaols for improvement: from chaos to order for improving diabetes care. Clin Chem 2011; 57: 205–214.
14. 1c: re-analyzing the DCCT with respect to time-dependent effects. Diabetologia 2010; 53: 1093–1098.
15. Clements M, Matuleviciene V, Attvall S, Ekelund M, Pivodic A, Dahlqvist S et al. Predicting the efectiveness of insulin pump theraphy on glycemic control in clinical practice: a retrospective study of patients with Type 1 diabetes from 10 outpatient diabetes clinics in Sweden over 5 years. Diabetes Technol Ther 2015; 17: 25–29.
16. Patton SR, Clements MA, Fridlington A, Cohoon C, Turpin AL, DeLurgio SA. Frequency of mealtime insulin bolus as a proxy measure of adherence for children and youths with Type 1 diabetes mellitus. Diabets Technol Ther 2013; 15: 124–128.